Verrica refiles seeking FDA approval of viral skin disease drug VP-102

Headquarters of US Food and Drug Administration (FDA)

Grandbrothers/iStock Editorial via Getty Images

Verrica Pharmaceuticals (NASDAQ:VRCA) resubmitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of VP-102 to treat a viral skin infection called molluscum contagiosum (MC).

The FDA haddeficiencies

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!